404 related articles for article (PubMed ID: 22039050)
1. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
[TBL] [Abstract][Full Text] [Related]
2. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.
Ji L; Xu J; Liu J; Amjad A; Zhang K; Liu Q; Zhou L; Xiao J; Li X
J Biol Chem; 2015 May; 290(18):11729-40. PubMed ID: 25767119
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
5. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
6. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.
Lee MK; Pardoux C; Hall MC; Lee PS; Warburton D; Qing J; Smith SM; Derynck R
EMBO J; 2007 Sep; 26(17):3957-67. PubMed ID: 17673906
[TBL] [Abstract][Full Text] [Related]
8. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
10. Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling.
Hough C; Radu M; Doré JJ
PLoS One; 2012; 7(8):e42513. PubMed ID: 22880011
[TBL] [Abstract][Full Text] [Related]
11. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
[TBL] [Abstract][Full Text] [Related]
12. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
[TBL] [Abstract][Full Text] [Related]
13. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
15. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
17. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells.
Hong HK; Song CY; Kim BC; Lee HS
Transl Res; 2006 Oct; 148(4):171-9. PubMed ID: 17002919
[TBL] [Abstract][Full Text] [Related]
18. TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma.
Du M; Chen W; Zhang W; Tian XK; Wang T; Wu J; Gu J; Zhang N; Lu ZW; Qian LX; Fei Q; Wang Y; Peng F; He X; Yin L
Biomed Pharmacother; 2018 Mar; 99():688-696. PubMed ID: 29710466
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
20. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK; Smith JA; Schiemann WP
J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
